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A best evidence topic was constructed according to a structured protocol. The question addressed was
whether laparoscopic ileocecal resection for Crohn’s disease is associated with higher morbidity rates in
comparison to open surgery. From a total of 123 articles, 11 studies provided the best available evidence
on this topic. Five observational studies, two randomized trials, three follow up studies and a meta-
analysis were identiﬁed. The primary author, date and country of publication, study type, patient
group characteristics, relevant outcome parameters and results of these papers were tabulated. Peri-
operative morbidity was either similar between the laparoscopic and the open group, or favored the
laparoscopic approach. Convalescence was consistently reported to be shorter in the laparoscopic
treatment arm, at cost of longer duration of surgery. Limited evidence suggests lower incidence of small
bowel obstruction and disease recurrence for laparoscopy, although follow up data are of poor quality. It
may be concluded that laparoscopic ileocecal resection is a safe alternative approach to open surgery for
uncomplicated Crohn’s disease, provided laparoscopic expertise is available.
 2013 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.1. Introduction
A best evidence topic was constructed according to a structured
protocol. This has been previously fully described.12. Clinical scenario
The case of a young male patient with uncomplicated Crohn’s
ileitis refractory to medical treatment is discussed in the weekly
indication meeting of your department. Considering the available
expertise in advanced laparoscopic surgery, you suggest offering a
laparoscopic procedure to the patient. Colleagues from the
gastroenterology department argue that the laparoscopic tech-
nique imposes risks to the safety of the anastomosis, because of the
frail tissue and the long-term systemic therapy with steroids. You
decide to search the literature yourself for the best available01 Keratea Attikis, Athens,
A. Antoniou).
ciates Ltd. Published by Elsevier Ltevidence on surgical approaches, and repeat the meeting before
proceeding to surgery.
3. Three-part question
In [patients with Crohn’s disease (CD)] is [laparoscopic surgery]
associated with [higher surgical morbidity]?
4. Search strategy
Medline from inception up to July 2013: ([ileocolic resection] OR
[ileocaecal resection] OR [caecectomy]) AND [laparoscopy]. Titles
and abstracts were scrutinized; full texts of related articles were
retrieved. Only studies written in the English language were
considered.
5. Search outcome
One hundred and twenty three records were identiﬁed. Eleven
articles were not in English, 61 were not relevant, 21 were cased. All rights reserved.
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population, 3 did not report on postoperative complications, and 2
regarded robotic-assisted surgery. Eleven articles were considered
to provide the best available evidence on this topic.
6. Results
The results of the 11 articles are summarized in the Table 1.
7. Discussion
Laparoscopic surgery offers a less invasive alternative to open
ileocecal resection in patients with CD. The laparoscopic approach
presumably reduces surgical stress and the possibility of anasto-
mosis- and wound-related complications in immunosuppressed
patients. Further, itmaydecrease the extentof adhesions,which is of
speciﬁc importance in a patient population with high possibility of
multiple operations for recurrent disease.13 Nevertheless, although
open surgery allows direct tissue manipulation and facile mechan-
ical or hand-sewn anastomosis, laparoscopic ileocecal resection
requires mobilization of the right colon and exteriorization of the
terminal ileum and proximal ascending colon through a mini lapa-
rotomy. These manipulations may compromise the structural and
functional integrity, and the blood supply of the bowel. Laparoscopy
may further underestimate the extent of the disease, due to the loss
of tactile feedback of the affected bowel.
Bemelman et al.2 provided an early retrospective analysis of 78
patients with CD, subjected to laparoscopic or open surgery in the
same time period, matched for demographic characteristics, but
with different trends of administration of steroids (19 mg/day
laparoscopic vs. 6 mg/day open; p < 0.001) and tube feeding (43%
laparoscopy vs. 0% open; p < 0.001) in the perioperative period.
Patient-oriented outcomes were similar for the open and the
laparoscopic approach, although hospital stay favored laparoscopy.
Their results may however be biased, due to this variation in
perioperative care. Operating time favored the open approach, with
a mean difference of 34 min (p < 0.001). Eshuis et al.3 published an
8.5-year follow up report of this study, which demonstrated no
difference in intestinal disease recurrence (23% laparoscopic vs. 22%
open, p-value not signiﬁcant). Mean follow up time was 8.3 years
for the laparoscopic arm and 8.6 years for the open arm (p ¼ 0.38).
Milsom et al. performed the ﬁrst randomized trial on this
subject.4 This study had however multiple methodological short-
comings (no information on randomization method, not blinded,
not reporting on dropouts, as-treated analysis) and fails to provide
high quality evidence. Morbidity was 16% and 31% in the laparo-
scopic and the open treatment arms, respectively, a result which
reached statistical signiﬁcance (p ¼ 0.05). The incidence of anas-
tomotic leak was however similar (3% and 0%, respectively), as
were the requirements of morphine analgesia. Duration of surgery
favored the open approach (85 min vs. 140 min; p < 0.00001). The
long-term follow up study by Stocchi et al.,5 reporting on the
outcome of 56 patients of the initial study population, demon-
strated no difference in endoscopic recurrence and clinical recur-
rence requiring surgery.
In a high-quality, detailed retrospective report by Bergamaschi
et al.,6 92 patients with CD were subjected to laparoscopic (n ¼ 39)
or open surgery (n ¼ 53). Although the patient samples were
treated in different time periods, they were matched for de-
mographic, disease, and treatment characteristics. Thirty-day
morbidity did not differ between the laparoscopic and the open
group (10% vs. 9%, respectively). Two of 39 patients subjected to
laparoscopic surgery required suture reinforcement of the anasto-
mosis, due to air leak at control colonoscopy, which was only per-
formed in the laparoscopic arm. Similar to previous reports, longerduration of surgery was registered for the laparoscopic approach
(185 min vs. 105 min, p < 0.001). Duration of follow up of 84 pa-
tients was reported to be similar between the two groups at 5 years,
with low possibility of dropout bias. Small bowel obstruction
occurred in 11% of the laparoscopic group and in 35% of the open
group (p ¼ 0.02). Disease recurrence based on an objective disease
activity index was registered in 28% and 29% of the laparoscopic
and the open group, respectively (p ¼ 0.91).
Lowney et al. reported on the perioperative and the 3-year
outcome of 113 patients subjected to laparoscopic and conventional
ileocecal resection.7 Surgical morbidity was 19% and 34%, respec-
tively; this difference however did not reach signiﬁcance. Disease
relapse requiring surgery occurred in 3% of the laparoscopic group
and 13% of the open group. Strong evidence on more complex
disease characteristics in the open treatment arm, with 11 cases of
organ ﬁstulization vs. one case in the laparoscopic group, must be
taken into account.
In a more recent randomized trial of adequate quality,8 Maar-
tense et al. reported on 60 patients with CD. Longer duration of
surgery was evident for the laparoscopic approach (115 vs. 90 min,
p ¼ 0.003). Thirty-day morbidity (10% vs. 33%, p ¼ 0.03), return to
normal diet (4 vs. 5 days, p < 0.003), and hospital stay (5 vs. 7 days,
p¼ 0.008) favored laparoscopy. In the long-term follow up study by
Eshuis et al.,9 no difference in treatment outcomes was identiﬁed
with regard to disease recurrence (39% vs. 45%, respectively), in-
testinal recurrence requiring surgery (7% vs. 12%, respectively) and
reoperation for ileus (0% vs. 4% respectively) for the laparoscopic
and the open approach.
The meta-analysis by Tilney et al., in 2006 provided pooled
evidence of outcomes of low to high quality observational studies,10
including the randomized trial by Milsom et al.4 The analysis
favored the open approach with regard to operative time (weighted
mean difference 30 min, 95% conﬁdence interval 11e48). Anasto-
motic leak and abscess formationwas similar between groups. First
bowel movement, return to normal diet and hospital stay favored
the laparoscopic approach, heterogeneity being however evident in
these outcome measures. The majority of studies were of poor
quality, and sensitivity analysis of quality studies was undertaken,
which validated the combined estimates of operating time, post-
operative ileus and duration of hospital stay. Surgical morbidity
was however not considered in this analysis.
A population-based analysis of the National Surgical Quality
Program database by Lee et al. provided data on 644 laparoscopic
and 1273 open ileocecal resections between 2005 and 2009.11
Although both major (8% vs. 15%; p < 0.0001) and minor compli-
cations (9% vs. 13% open, p < 0.0001) presented with a lower
incidence in the laparoscopic cohort, signiﬁcant selection bias were
inevitable and preclude generalization of results. This study pro-
vides however an estimate of operative morbidity in selected pa-
tients undergoing laparoscopic surgery for CD.
The most recent study by Makni et al.,12 provides the outcome
of 129 patients with similar demographic and disease character-
istics between the laparoscopic and the open treatment arm. In
accordance with previous reports, operating time for laparoscopic
surgery was longer (158 min vs. 130 min, p < 0.001). Although
overall morbidity was similar (8% laparoscopic vs. 11% open), there
was a trend toward a higher incidence of anastomotic leak in the
open group (0% vs. 8%, p ¼ 0.06). The duration of postoperative
ileus (2.9 vs. 3.4 days, p ¼ 0.02) and hospitalization (7 vs. 9 days,
p ¼ 0.001) was shorter in the laparoscopic treatment group. Small
bowel obstruction occurred in 5% and 9% of the laparoscopic and
the open treatment arm, respectively (p not signiﬁcant). Clinical
recurrence required surgery in 19% of the open group and none in
the laparoscopic group (p ¼ 0.001). A longer follow up period for
the open treatment arm should be considered (26 vs. 34 months).
Table 1
Best evidence papers.
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Table 1 (continued)
CD, Crohn’s disease.
lap, laparoscopic.
ns, not signiﬁcant.
OR, odds ratio.
WMD, weighted mean difference.
CI, conﬁdence interval.
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BEST EVIDENCE TOPIC8. Clinical bottom line
Best available evidence suggests that laparoscopic ileocecal
resection for CD provides at least similar perioperative outcomes as
open surgery. Shorter convalescence is consistently reported, at the
cost of longer operative time. Evidence is provided mainly by
retrospective observational studies; a single randomized trial of
adequate quality and a meta-analysis converge to these conclu-
sions. Although reliable long-term data are largely lacking, studies
with similar duration of follow up across treatment arms demon-
strate similar or lower incidence of disease recurrence and less
frequent events of small bowel obstruction for laparoscopic sur-
gery. It may be concluded, that laparoscopic ileocecal resection is a
safe alternative approach to open surgery for uncomplicated
Crohn’s disease, provided laparoscopic expertise is available.Ethical approval
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